Search Results 261-270 of 15984 for melatonin receptor agonists

  1. Lung Tumors Clinical Trials - Mayo Clinic Research

    ... receptor positive bronchial neuroendocrine tumors that have spread to other places in the body (advanced). Radioactive drugs, such as lutetium Lu 177 ...

  2. Comparing Retreatment of 177Lu-DOTATATE PRRT Versus Everolimus in Patients With Metastatic Unresectable Midgut Neuroendocrine Tumors, NET RETREAT Trial - Mayo Clinic

    The purpose of this study is tol compare the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) to the usual approach of ...

  3. Faculty - Division of Endocrinology, Diabetes, Metabolism, and Nutrition-Research - Mayo Clinic Research

    An expert faculty guides research in the Mayo Clinic Division of Endocrinology, Diabetes, Metabolism, and Nutrition.

  4. Elacestrant (oral route) - Mayo Clinic

    Elacestrant is used to treat estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ESR-1 mutated, advanced or ...

  5. Define in Humans With Compensated CHF and Renal Dysfunction, the Modulating Action of Chronic AT1 Receptor Blockade in Addition to ACE Inhibition on Cardiorenal and Humoral Function - Mayo Clinic

    The belief is that the chronic AT1 receptor blockade in subjects with compensated CHF and renal dysfunction will improve renal function with increased sodium ...

  6. Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

    Triple negative means that the breast cancer does not express other hormone receptors called ER alpha, progesterone, and HER2. In some people with triple ...

  7. Douglas A. Husmann, M.D. - Mayo Clinic Faculty Profiles

    Aberrant androgen physiology in penile development. Dr. Husmann was part of the laboratory group that was one of the first to clone the androgen receptor ...

  8. Study of Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis - Mayo Clinic

    testing), IP receptor agonists (selexipag), endothelin receptor antagonists, phosphodiesterase type 5 inhibitors (PDE5-Is), or soluble guanylate cyclase

  9. Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer - Mayo Clinic

    ... Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer ... receptor 2 (HER2) negative ... agonist/antagonist are eligible. Subjects with ...

  10. A Study to Evaluate Triapine Combined with Lutetium Lu 177 Dotatate for Gastroenteropancreatic Neuroendocrine Tumors - Mayo Clinic

    Pregnant women are excluded from this study because triapine is an RNR inhibitor and Lutetium Lu 177 Dotatate is a peptide receptor radionuclide therapy with ...